Method for measuring volatile drug quality of tracheitis rubber ointment and application thereof

The content of camphor, borneol, menthol, methyl salicylate and turpentine in bronchitis rubber plaster was determined by gas chromatography, which solved the problem of lack of quality control in the existing technology and ensured the quality and efficacy of the product.

CN118330066BActive Publication Date: 2026-11-10HENAN LINGRUI PHARMA
View PDF 2 Cites 0 Cited by

Patent Information

Application Number
CN202410447887.2
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2024-04-15
Publication Date
2026-11-10
Estimated Expiration
2044-04-15

AI Technical Summary

Technical Problem

Current technology lacks an effective method to determine the content of volatile drugs in bronchitis plasters, which affects product quality and efficacy.

Method used

Gas chromatography was used with a polyethylene glycol 20000 stationary phase capillary column, programmed temperature rise, split injection, and nitrogen carrier gas, combined with the internal standard method, to determine the content of specific components in camphor, borneol, menthol, methyl salicylate, and turpentine.

Benefits of technology

This method enables accurate determination of the volatile drug content in bronchitis plasters, ensuring product quality and efficacy. It is simple to operate, fast to measure, highly precise, and stable.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118330066B_ABST
    Figure CN118330066B_ABST
Patent Text Reader

Abstract

The present application relates to the tracheitis rubber ointment volatile drug quality determination method and its application, effectively solve the determination of volatile drug content in tracheitis rubber ointment, ensure product quality and curative effect problem, chromatographic condition and system applicability test: with polyethylene glycol 20000 stationary phase capillary column, using program temperature, split sample, FID detection, carrier gas nitrogen;Take naphthalene to prepare internal standard solution;Respectively prepare camphor, menthol, borneol, isoborneol, methyl salicylate, alpha-pinene solution, place in the same amount bottle, add internal standard solution, dilute with ethyl acetate, form control solution;Tracheitis rubber ointment is added with water, heated to reflux extraction, then add toluene, cooling, toluene liquid is diluted with ethyl acetate, add internal standard solution, dilute with ethyl acetate, form sample solution;Respectively take control solution and sample solution, inject into gas chromatograph, determine, calculate the content of volatile drug in sample solution by correction factor, the method is simple, easy to operate, fast, accurate.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] This invention relates to the field of pharmaceutical technology, specifically to a method for determining the quality of volatile drugs in bronchitis rubber plaster and its application. Background Technology

[0002] The bronchitis plaster is composed of 17 medicinal herbs, including red peony root, lindera root, angelica root, cinnamon twig, raw aconite root, perilla seed, white aconite root, long pepper, raw arisaema root, poppy husk, white mustard seed, soapberry, borneol, menthol, turpentine oil, camphor, and methyl salicylate. It has the effects of warming the lungs, resolving phlegm, relieving asthma, and stopping cough. It is used to treat bronchitis caused by cold and also has a preventative effect against bronchitis.

[0003] Camphor, a volatile drug, possesses pharmacological effects such as anti-inflammatory, analgesic, antibacterial, and penetration-enhancing properties. Borneol exhibits pharmacological effects including reducing swelling and pain, antibacterial, anti-inflammatory, and promoting the transdermal absorption of other drugs. Menthol provides cooling and antipruritic effects and promotes transdermal absorption. Methyl salicylate can promote local blood circulation; when applied topically, it can cause vasodilation in the skin, resulting in anti-swelling, anti-inflammatory, and analgesic effects. Camphor, menthol, and borneol are also commonly used transdermal absorption enhancers in topical preparations. Turpentine oil possesses pharmacological effects such as antitumor, antifungal, and anti-allergic properties. α-Pinene, a representative component, is not only present in high amounts but also has therapeutic effects on bronchitis.

[0004] The aforementioned volatile drugs are used in large quantities in bronchitis plasters, have clearly defined chemical compositions, and are closely related to therapeutic efficacy, directly affecting product quality and efficacy. Therefore, determining the content of these volatile drugs to achieve product quality control and ensure efficacy is crucial. However, existing standards for quality control do not include quantitative determination methods for these volatile drugs. With the continuous improvement of product quality requirements and technological advancements, determining their content is of great significance for the quality control of bronchitis plasters. However, no publicly available reports have yet been published on how to determine the quality of volatile drugs in bronchitis plasters to achieve quality control. Summary of the Invention

[0005] In view of the above situation and to overcome the defects of the prior art, the purpose of this invention is to provide a method for determining the quality of volatile drugs in bronchitis plaster and its application, which can effectively solve the problem of determining the content of volatile drugs in bronchitis plaster and ensure product quality and efficacy.

[0006] The technical solution provided by this invention is a method for determining the quality of volatile drugs in bronchitis adhesive plaster. The volatile drugs in the bronchitis adhesive plaster include camphor, borneol, menthol, methyl salicylate, and turpentine oil. The borneol contains borneol and isoborneol, and the turpentine oil contains α-pinene. The content determination method is as follows:

[0007] (1) Chromatographic conditions and system suitability test:

[0008] A capillary column with a polyethylene glycol 20000 (PEG-20M) stationary phase, a length of 30 m, an inner diameter of 0.32 mm, and a film thickness of 0.50 μm was used. A programmed temperature ramp was employed: initial temperature 50–70 °C, held for 0–3 min, then increased to 180–220 °C at a rate of 3–9 °C / min, and held for 0–10 min. Split injection was used with a split ratio of 1–20:1. The injection port temperature was 160–200 °C. An FID detector was used with a detector temperature of 220–250 °C. The carrier gas was 9.999% nitrogen, with a flow rate of 0.7–1.5 mL / min.

[0009] (2) Preparation of internal standard solution: Take naphthalene, accurately weigh it, add ethyl acetate to prepare a solution containing 3 to 7 mg per 1 mL, which is used as internal standard solution;

[0010] (3) Preparation of reference solution: Weigh 15-30 mg of camphor reference, 5-15 mg of menthol reference, 10-20 mg of borneol reference, 5-15 mg of isoborneol, 20-30 mg of methyl salicylate reference, and 5-15 mg of α-pinene reference accurately, place them in the same 25 mL volumetric flask, add 5 mL of internal standard solution, dilute with ethyl acetate to 25 mL, shake well to prepare reference solution;

[0011] (4) Preparation of sample solution: Take 210cm of bronchitis rubber plaster 2 Cut the sample into small pieces, remove the cap, place it in a 250mL flask, add 100mL of water, and follow the method of volatile oil determination (Chinese Pharmacopoeia 2020 Edition, Part IV, General Chapter 2204). Add water from the top of the measuring apparatus until it fills the graduated part and overflows into the flask. Add 2mL of toluene, heat and reflux for 1-4 hours, cool to room temperature, take the toluene solution, dilute with 3-5mL of ethyl acetate, filter through filter paper lined with anhydrous sodium sulfate, place the filtrate in a 50mL volumetric flask, wash the container and filter with 1-5mL of ethyl acetate 1-3 times, combine the washings in the same volumetric flask, accurately add 10mL of internal standard solution, dilute with ethyl acetate to 50mL, shake well to obtain the sample solution.

[0012] (5) Determination method: Accurately pipette 1 μl of the reference solution and the sample solution into the gas chromatograph and measure them. The peak area of ​​the internal standard and the peak area of ​​the reference standard are calculated to obtain the correction factor. The content of volatile drugs in the sample solution is calculated through the correction factor.

[0013] Equation (1)

[0014] Equation (2)

[0015] Equation (3)

[0016] In the formula: As is the peak area or peak height of the internal standard;

[0017] A R The peak area or peak height of the reference standard;

[0018] Cs is the concentration of the internal standard (mg / ml);

[0019] C R The concentration of the reference standard is (mg / ml).

[0020] C X The concentration of the test sample (mg / ml);

[0021] A X The peak area or peak height of the test sample;

[0022] A′s represents the peak area or peak height of the internal standard in the test sample;

[0023] C′s is the concentration (mg / ml) of the internal standard in the test sample;

[0024] M X The area of ​​the test sample (cm²) 2 ).

[0025] In the aforementioned split injection, the liquid sample rapidly vaporizes after entering the injection port during injection. A small amount of the sample enters the capillary column, while most of the sample exits from the split outlet. The ratio of the sample entering the capillary column to the sample exiting the split outlet can be controlled by adjusting the ratio of the column flow rate to the split flow rate. The ratio of the split flow rate to the column flow rate is called the split ratio.

[0026] The aforementioned determination method is applied to the quality control of volatile drugs in bronchitis plaster. The quality control involves specifying that the content of volatile drugs camphor, menthol, borneol, methyl salicylate, and turpentine oil is as follows: per 100 cm³... 2 Contains camphor (C 10 H 16O Not less than 14.55 mg; Menthol (C 10 H 20O Not less than 5.00mg; contains borneol (C 10 H 18O Not less than 10.50 mg; contains isoborneol (C 10 H 18O Not less than 5.90 mg; contains methyl salicylate (C8H) 8O3 The content shall not be less than 15.20 mg, and the content of α-pinene shall not be less than 4.55 mg.

[0027] The method of this invention is simple, easy to operate, fast and accurate, and effective for determining the volatile drug content of bronchitis plaster, ensuring the quality and efficacy of bronchitis plaster. It is a major innovation in the quality control of bronchitis plaster and has significant economic and social benefits. Attached Figure Description

[0028] Figure 1 The chromatogram showing the leading peak of camphor in this invention;

[0029] Figure 2 This is a gas chromatogram of the reference solution of the present invention;

[0030] Figure 3 This is a gas chromatogram of the sample solution of the present invention. Detailed Implementation

[0031] The specific implementation of the present invention will be described in detail below with reference to examples and specific circumstances.

[0032] The present invention can be described in the following embodiments.

[0033] Example 1

[0034] This invention discloses a method for determining the quality of volatile drugs in bronchitis adhesive plaster. The volatile drugs in the bronchitis adhesive plaster are camphor, borneol, menthol, methyl salicylate, and turpentine oil. The borneol contains borneol and isoborneol, and the turpentine oil contains α-pinene. The content determination method is as follows:

[0035] (1) Chromatographic conditions and system suitability test:

[0036] A capillary column with a polyethylene glycol 20000 (PEG-20M) stationary phase, a length of 30 m, an inner diameter of 0.32 mm, and a film thickness of 0.50 μm was used. A programmed temperature ramp was employed: an initial temperature of 60 °C, held for 2 min, then increased to 200 °C at a rate of 7.5 °C / min, and held for 7 min. Split injection was used with a split ratio of 20:1; the injection port temperature was 180 °C; an FID detector was used with a detector temperature of 230 °C; and the carrier gas was 9.999% nitrogen at a flow rate of 0.8 mL / min.

[0037] (2) Preparation of internal standard solution: Weigh naphthalene accurately and add ethyl acetate to prepare a solution containing 5 mg per 1 mL as internal standard solution;

[0038] (3) Preparation of reference solution: Take 25 mg of camphor reference, 10 mg of menthol reference, 15 mg of borneol reference, 10 mg of isoborneol, 25 mg of methyl salicylate reference, and 10 mg of α-pinene reference, accurately weigh them, place them in the same 25 mL volumetric flask, add 5 mL of internal standard solution, dilute with ethyl acetate to 25 mL, shake well, and the reference solution is prepared.

[0039] (4) Preparation of sample solution: Take 210cm of bronchitis rubber plaster 2 Cut the sample into small pieces, remove the cap, place it in a 250mL flask, add 100mL of water, and follow the method of volatile oil determination (Chinese Pharmacopoeia 2020 Edition, Part IV, General Chapter 2204). Add water from the top of the measuring apparatus until it fills the graduated part and overflows into the flask. Add 2mL of toluene, heat and reflux for 3 hours, cool to room temperature, take the toluene solution, dilute with 3mL of ethyl acetate, filter through filter paper lined with anhydrous sodium sulfate, place the filtrate in a 50mL volumetric flask, wash the container and filter with 1-5mL of ethyl acetate 1-3 times, combine the washings in the same volumetric flask, accurately add 10mL of internal standard solution, dilute with ethyl acetate to 50mL, shake well to obtain the sample solution.

[0040] (5) Determination method: Accurately pipette 1 μl of the reference solution and the sample solution into the gas chromatograph and measure them. The peak area of ​​the internal standard and the peak area of ​​the reference standard are calculated to obtain the correction factor. The content of volatile drugs in the sample solution is calculated through the correction factor.

[0041] Example 2

[0042] This invention discloses a method for determining the quality of volatile drugs in bronchitis adhesive plaster, the specific determination steps of which are as follows:

[0043] (1) Chromatographic conditions and system suitability test:

[0044] A capillary column with a polyethylene glycol 20000 (PEG-20M) stationary phase, a length of 30 m, an inner diameter of 0.32 mm, and a film thickness of 0.50 μm was used. A programmed temperature ramp was employed: an initial temperature of 60 °C, held for 2 min, then increased to 200 °C at a rate of 7.5 °C / min, and held for 5 min. Split injection was used with a split ratio of 15:1; the injection port temperature was 170 °C; an FID detector was used with a detector temperature of 240 °C; and the carrier gas was 9.999% nitrogen at a flow rate of 1.0 mL / min.

[0045] (2) Preparation of internal standard solution: Take naphthalene, accurately weigh it, add ethyl acetate to prepare a solution containing 4 mg per 1 mL, and use it as internal standard solution;

[0046] (3) Preparation of reference solution: Accurately weigh 16 mg of camphor reference, 6 mg of menthol reference, 12 mg of borneol reference, 6 mg of isoborneol, 22 mg of methyl salicylate reference, and 6 mg of α-pinene reference, place them in the same 25 mL volumetric flask, add 5 mL of internal standard solution, dilute with ethyl acetate to 25 mL, shake well to prepare reference solution;

[0047] (4) Preparation of sample solution: Take 210cm of bronchitis rubber plaster 2Cut the sample into small pieces, remove the cap, place it in a 250mL flask, add 100mL of water, and follow the method of volatile oil determination (Chinese Pharmacopoeia 2020 Edition, Part IV, General Chapter 2204). Add water from the top of the measuring apparatus until it fills the graduated part and overflows into the flask. Add 2mL of toluene, heat and reflux for 2 hours, cool to room temperature, take the toluene solution, dilute with 4mL of ethyl acetate, filter through filter paper lined with anhydrous sodium sulfate, place the filtrate in a 50mL volumetric flask, wash the container and filter with 1-5mL of ethyl acetate 1-3 times, combine the washings in the same volumetric flask, accurately add 10mL of internal standard solution, dilute with ethyl acetate to 50mL, shake well to obtain the sample solution.

[0048] (5) Determination method: Accurately pipette 1 μl of the reference solution and the sample solution into the gas chromatograph and measure them. The peak area of ​​the internal standard and the peak area of ​​the reference standard are calculated to obtain the correction factor. The content of volatile drugs in the sample solution is calculated through the correction factor.

[0049] Example 3

[0050] This invention discloses a method for determining the quality of volatile drugs in bronchitis adhesive plaster, the specific determination steps of which are as follows:

[0051] (1) Chromatographic conditions and system suitability test:

[0052] A capillary column with a polyethylene glycol 20000 (PEG-20M) stationary phase, a length of 30 m, an inner diameter of 0.32 mm, and a film thickness of 0.50 μm was used. The temperature was programmed: initial temperature 60 °C, held for 2 min, then increased to 200 °C at a rate of 6 °C / min, and held for 6 min. Split injection was used with a split ratio of 10:1. The injection port temperature was 190 °C. An FID detector was used with a detector temperature of 230 °C. The carrier gas was 9.999% nitrogen at a flow rate of 1.4 mL / min.

[0053] (2) Preparation of internal standard solution: Weigh naphthalene accurately and add ethyl acetate to prepare a solution containing 6 mg per 1 mL as internal standard solution;

[0054] (3) Preparation of reference solution: Take 28 mg of camphor reference, 13 mg of menthol reference, 18 mg of borneol reference, 13 mg of isoborneol, 28 mg of methyl salicylate reference, and 13 mg of α-pinene reference, accurately weigh them, place them in the same 25 mL volumetric flask, add 5 mL of internal standard solution, dilute with ethyl acetate to 25 mL, shake well, and the reference solution is prepared.

[0055] (4) Preparation of sample solution: Take 210cm of bronchitis rubber plaster 2Cut the sample into small pieces, remove the cap, place it in a 250mL flask, add 100mL of water, and follow the method of volatile oil determination (Chinese Pharmacopoeia 2020 Edition, Part IV, General Chapter 2204). Add water from the top of the measuring apparatus until it fills the graduated part and overflows into the flask. Add 2mL of toluene, heat and reflux for 4 hours, cool to room temperature, take the toluene solution, dilute with 5mL of ethyl acetate, filter through filter paper lined with anhydrous sodium sulfate, place the filtrate in a 50mL volumetric flask, wash the container and filter with 1-5mL of ethyl acetate 1-3 times, combine the washings in the same volumetric flask, accurately add 10mL of internal standard solution, dilute with ethyl acetate to 50mL, shake well to obtain the sample solution.

[0056] (5) Determination method: Accurately pipette 1 μl of the reference solution and the sample solution into the gas chromatograph and measure them. The peak area of ​​the internal standard and the peak area of ​​the reference standard are calculated to obtain the correction factor. The content of volatile drugs in the sample solution is calculated through the correction factor.

[0057] The application of the determination method described in Examples 1-3 in the quality control of volatile drugs in bronchitis plaster, wherein the quality control is as follows: the content of volatile drugs camphor, menthol, borneol, methyl salicylate, and turpentine oil is as follows per 100 cm³. 2 Contains camphor (C 10 H 16O Not less than 14.55 mg; Menthol (C 10 H 20O Not less than 5.00mg; contains borneol (C 10 H 18O Not less than 10.50 mg; contains isoborneol (C 10 H 18O Not less than 5.90 mg; contains methyl salicylate (C8H) 8O3 The content shall not be less than 15.20 mg, and the content of α-pinene shall not be less than 4.55 mg.

[0058] As can be seen from the above, this invention is the first to study a method for determining the content of volatile drugs in bronchitis plaster. Through extensive experimental research, a GC method for determining the content of camphor, borneol, menthol, methyl salicylate, and turpentine in bronchitis plaster was established. The content determination method established in this invention has high precision, good accuracy, and good stability, providing a reliable way for quality control of volatile components in bronchitis plaster. This allows for more comprehensive control of product quality, ensuring product stability, uniformity, and controllable quality, thus guaranteeing therapeutic efficacy. Experiments have shown that this method has achieved very good technical results. Relevant information is as follows:

[0059] Experiment 1: An investigation into the various process conditions for determining the quality of volatile drugs in bronchitis rubber plaster.

[0060] 1.1 Instruments and Reagents

[0061] Chromatograph: Gas chromatograph, Agilent 2030;

[0062] Column: Agilent HP-INNOWAX (30m × 0.32mm × 0.50um);

[0063] Reagents: Naphthalene (Sinopharm Chemical Reagent Co., Ltd.), Toluene (Beijing Chemical Plant), Ethyl acetate (Tianjin Kemio Chemical Reagent Co., Ltd.), Anhydrous sodium sulfate (Tianjin Kemio Chemical Reagent Co., Ltd.); Nitrogen, high-purity nitrogen, 99.999% purity.

[0064] Reference standards: Camphor, batch number 110747-202011, content 97.0%; Borneol, batch number 110743-201906, content 99.6%; Isoborneol, batch number 111512-201903, content 96.7%; Menthol, batch number 110728-201907, content 96.9%; Methyl salicylate, batch number 110707-202015, content 100.0%; α-Pinene, batch number 110897-201903, content 99.9%, all purchased from the China National Institutes for Food and Drug Control.

[0065] Samples: Bronchitis plaster, provided by Henan Lingrui Pharmaceutical Co., Ltd., batch numbers: 210201, 210202, 210203; Hunan Xinglinchun Pharmaceutical Co., Ltd., batch numbers: 201205, 210101, 210301; Jinzhou Zijin Pharmaceutical Co., Ltd., batch numbers: 2012002, 2101205, 2103001.

[0066] 1.2 Investigation of the preparation method of the test solution

[0067] 1.2.1 Investigation of extraction methods and extraction solvents

[0068] Based on literature review, three extraction methods were employed: ultrasonic extraction, reflux extraction, and volatile oil extraction.

[0069] Method 1: Extraction using a volatile oil extractor: Take 210 cm of this product... 2Cut the sample into small pieces, remove the cap, place it in a 250ml flask, add 100ml of water, and follow the method of volatile oil determination (Method A) in General Chapter 2204 of Part IV of the 2020 edition of the Chinese Pharmacopoeia. Add water from the top of the measuring apparatus until it fills the graduated part and overflows into the flask. Add 2ml of toluene, heat under reflux for 3 hours, cool, take the toluene solution, dilute with 3ml of ethyl acetate, filter through filter paper lined with anhydrous sodium sulfate, place the filtrate in a 50ml volumetric flask, wash the container and filter with 1-5mL of ethyl acetate in 1-3 portions, combine the washings in the same volumetric flask, accurately add 10ml of internal standard solution, dilute with ethyl acetate to 50mL, shake well, and the product is ready.

[0070] Method 2: Ultrasonic extraction: Take 210 cm of this product 2 Cut into small pieces, remove the cap and liner, place in a stoppered glass bottle, add 20 ml of ethyl acetate, extract by sonication for 25 min, filter, place the filtrate in a 50 ml volumetric flask, wash the container and filter with 1-5 mL of ethyl acetate 1-3 times, combine the washings in the same volumetric flask, accurately add 10 ml of internal standard solution, dilute with ethyl acetate to 50 mL, shake well, and the product is ready.

[0071] Method 3: Reflux extraction: Take 210 cm of this product 2 Cut into small pieces, remove the cap liner, place in a round-bottom flask, add 200 ml of ethyl acetate, heat under reflux for 2 hours, filter, evaporate the solvent, add ethyl acetate to dissolve, place in a 50 ml volumetric flask, accurately add 10 ml of internal standard solution, dilute with ethyl acetate to 50 mL, shake well, and the product is ready.

[0072] Method 4: Extraction using a volatile oil extractor: Take 210 cm of this product... 2 Cut the sample into small pieces, remove the cap, place it in a 250ml flask, add 100ml of water, and follow the method of volatile oil determination (Method A) in General Chapter 2204 of Part IV of the 2020 edition of the Chinese Pharmacopoeia. Add water from the top of the measuring apparatus until it fills the graduated part and overflows into the flask. Add 2ml of petroleum ether (60-90), heat and reflux for 3 hours, cool, take the petroleum ether (60-90) solution, dilute with 3ml of ethyl acetate, filter through filter paper lined with anhydrous sodium sulfate, place the filtrate in a 50ml volumetric flask, wash the container and filter with 1-5mL of ethyl acetate 1-3 times, combine the washings in the same volumetric flask, accurately add 10ml of internal standard solution, dilute with ethyl acetate to 50mL, shake well, and the product is ready.

[0073] The results showed that Method 1, the volatile oil extractor, extracted fewer impurities and had a higher content; Method 2, the ultrasonic extraction, was incomplete; Method 3, the reflux extraction, had more impurities; and Method 4, the extraction was incomplete. Therefore, the volatile oil extractor was selected as the extraction method, and toluene was chosen as the extraction solvent.

[0074] 1.2.2 Examination of Sample Quantity

[0075] The sample size required for extracting volatile drugs from bronchitis plaster was investigated.

[0076] Test method: Take 140cm of this product respectively 2 210cm 2 280cm 2 350cm 2 Cut the sample into small pieces, remove the cap, place it in a 250ml flask, add 100ml of water, and follow the method of volatile oil determination (Method A) in General Chapter 2204 of Part IV of the 2020 edition of the Chinese Pharmacopoeia. Add water from the top of the measuring apparatus until it fills the graduated part and overflows into the flask. Add 2ml of toluene, heat under reflux for 3 hours, cool, take the toluene solution, dilute with 3ml of ethyl acetate, filter through filter paper lined with anhydrous sodium sulfate, place the filtrate in a 50ml volumetric flask, wash the container and filter with 1-5mL of ethyl acetate in 1-3 portions, combine the washings in the same volumetric flask, accurately add 10ml of internal standard solution, dilute with ethyl acetate to 50mL, shake well, and the product is ready.

[0077] The results showed that the sample size of the bronchitis plaster was 210 cm. 2 (Area of ​​two pieces of rubber plaster), the plaster content per unit area is the highest. The results are shown in Table 1.

[0078] Table 1. Results of content determination in extracts obtained from different extraction amounts (mg / 100cm³) 2 )

[0079]

[0080] 1.2.3 Examination of extraction time

[0081] The effects of different extraction times on volatile drugs in bronchitis plaster were investigated.

[0082] Test method: Take 210cm of this product 2 Cut the sample into small pieces, remove the cap, place it in a 250ml flask, add 100ml of water, and follow the method of volatile oil determination (Method A) in General Chapter 2204 of Part IV of the 2020 edition of the Chinese Pharmacopoeia. Add water from the top of the measuring apparatus until it fills the graduated section and overflows into the flask. Add 2ml of toluene, heat and reflux for 3 hours (1 hour, 2 hours, 4 hours), cool, take the toluene solution, dilute with 3ml of ethyl acetate, filter through filter paper lined with anhydrous sodium sulfate, place the filtrate in a 50ml volumetric flask, wash the container and filter with an appropriate amount of ethyl acetate several times, combine the washings in the same volumetric flask, accurately add 10ml of internal standard solution, dilute with ethyl acetate to the mark, shake well, and the product is ready.

[0083] The results showed that the bronchitis plaster could be completely extracted after 3 hours, and this experiment used an extraction time of 3 hours. The results are shown in Table 2.

[0084] Table 2 Results of different extraction times (mg / 100cm³) 2 )

[0085]

[0086] 1.2.4 Examination of constant volume

[0087] The effects of adjusting the test sample to different volumes on the chromatographic peak areas of camphor, menthol, borneol, isoborneol, methyl salicylate, and α-pinene were investigated.

[0088] Test method: Take 210cm of this product 2 Cut the sample into small pieces, remove the cap, place in a 250ml flask, add 100ml of water, and follow the method of volatile oil determination (Method A) in General Chapter 2204 of Part IV of the 2020 edition of the Chinese Pharmacopoeia. Add water from the top of the measuring apparatus until it fills the graduated section and overflows into the flask. Add 2ml of toluene, heat under reflux for 3 hours, cool, take the toluene solution, dilute with 3ml of ethyl acetate, filter through filter paper lined with anhydrous sodium sulfate, and place the filtrate into 25ml, 50ml, and 100ml volumetric flasks respectively. Wash the containers and filters with an appropriate amount of ethyl acetate several times, and combine the washings into the same volumetric flask. Accurately add 10ml of internal standard solution, and dilute with ethyl acetate to 25ml, 50ml, and 100ml respectively. Shake well to obtain the final product.

[0089] The results showed that when the volume was adjusted to 25 ml, the camphor peak exhibited a leading-edge peak with decreased symmetry. Figure 1 The volume was adjusted to 100 ml, and the repeatability test of α-pinene showed an RSD value of 3.25%, which does not meet the repeatability requirements of the Chinese Pharmacopoeia.

[0090] The final method for preparing the test solution was determined.

[0091] Take 210cm of this product 2 Cut the sample into small pieces, remove the cap, place it in a 250ml flask, add 100ml of water, and follow the method of volatile oil determination (Method A) in General Chapter 2204 of Part IV of the 2020 edition of the Chinese Pharmacopoeia. Add water from the top of the measuring apparatus until it fills the graduated part and overflows into the flask. Add 2ml of toluene, heat under reflux for 3 hours, cool, take the toluene solution, dilute with 3ml of ethyl acetate, filter through filter paper lined with anhydrous sodium sulfate, place the filtrate in a 50ml volumetric flask, wash the container and filter with 1-5mL of ethyl acetate in 1-3 portions, combine the washings in the same volumetric flask, accurately add 10ml of internal standard solution, dilute with ethyl acetate to 50mL, shake well, and the product is ready.

[0092] 1.3 Chromatographic conditions and system suitability test

[0093] 1.3.1 Investigation of Gas Phase Capillary Columns

[0094] Three types of gas-phase capillary columns were investigated: Agilent sp-3420 30m×0.32mm×0.25um (non-polar); Agilent HP-INNOWax 30m×0.32mm×0.50um (strongly polar); and Agilent SH-Rtx-Wax Cap 30m×0.32mm×1.8um (polar).

[0095] The results showed that under the same chromatographic conditions, there were significant differences between the columns, and the separation effects varied. Considering the column usage, the Agilent HP-INNOWax 30m×0.32mm×0.50um column was selected.

[0096] 1.3.2 Investigation of split injection

[0097] Different split ratios of 1:20, 1:10, 1:5 and 1:1 were investigated. The results showed that a split ratio of 1:20 was the best, with good separation of each chromatographic peak, and moderate retention time and peak area. Therefore, a split ratio of 1:20 was selected.

[0098] 1.3.3 Investigation of carrier gas velocity

[0099] Different carrier gas flow rates of 0.7 ml / min, 0.8 ml / min, 0.9 ml / min, 1.0 ml / min and 1.5 ml / min were selected for investigation. The results showed that the chromatographic peak resolution was better at 0.7-1.0 ml / min. In this experiment, the carrier gas flow rate of 0.8 ml / min was selected.

[0100] 1.3.4 Investigation of column temperature

[0101] Different temperature ramping methods were investigated, and method 5 was found to be the best. The temperature ramping methods are shown in Table 3.

[0102] Table 3. Programmed Heating Method

[0103]

[0104] Preferred chromatographic conditions

[0105] Chromatographic column: Capillary column with polyethylene glycol 20000 (PEG-20M) as stationary phase, column length 30m, inner diameter 0.32mm, film thickness 0.50μm; Column temperature programmed: initial temperature 60℃, hold for 2min, increase to 200℃ at 7.5℃ / min, hold for 7min; Split ratio 20:1, injection port temperature 180℃; FID detector temperature 230℃, carrier gas high-purity nitrogen, flow rate 0.8ml / min; Injection volume: 1ul; Theoretical plate number calculated based on naphthalene peak should not be less than 5000.

[0106] 1.4 Investigation of internal standard solution: After extensive experimentation, naphthalene was selected as the internal standard. The physicochemical properties of naphthalene are similar to those of the volatile drug to be tested. It can precipitate near the volatile drug to be tested in gas chromatography. Furthermore, the internal standard component is not present in bronchitis rubber plaster. This internal standard does not affect the volatile drug to be tested, making it a high-performance internal standard.

[0107] Take an appropriate amount of naphthalene, weigh it accurately, and add ethyl acetate to prepare a solution containing 5 mg per 1 ml, which will be used as an internal standard solution.

[0108] 1.5 Preparation of mixed reference solution: Accurately weigh 25 mg of camphor reference, 10 mg of menthol reference, 15 mg of borneol reference, 10 mg of isoborneol reference, 25 mg of methyl salicylate reference, and 10 mg of α-pinene reference, place them in the same 25 ml volumetric flask, accurately add 5 ml of internal standard solution, dilute with ethyl acetate to 25 mL, and shake well to obtain the solution.

[0109] 1.6 Methodological Examination

[0110] 1.6.1 Standard Curve and Linear Range

[0111] Accurately weigh appropriate amounts of camphor, menthol, borneol, isoborneol, methyl salicylate, and α-pinene reference standards, and place them in volumetric flasks to prepare mixed reference stock solutions containing 3.0444 mg camphor, 1.2083 mg menthol, 1.8995 mg borneol, 1.1145 mg isoborneol, 3.0264 mg methyl salicylate, and 1.1221 mg α-pinene per 1 ml. Accurately measure 0.5, 1, 2, 3.3, 4, 6, 8, and 10 ml of each of the above mixed reference solutions and place them in 10 ml volumetric flasks. Dilute with 1 mg / ml naphthalene internal standard solution to the required volume to prepare linear solutions of mixed reference standards containing internal standards at different concentrations. Accurately pipette 1 μl of each of the above eight mixed reference solutions and inject it into the gas chromatograph for determination. Plot a standard curve with the injection concentration (X) as the abscissa and the ratio of the peak area of ​​each component to the peak area of ​​the internal standard (Y) as the ordinate. The results are shown in Table 4.

[0112] Table 4. Results of the standard curve test

[0113]

[0114] 1.6.2 Precision Test

[0115] Accurately pipette the mixed reference solution from section "1.5" and inject it six times repeatedly under chromatographic conditions. Calculate the RSDs (Resolution Distributed) as the ratios of the peak areas of camphor, menthol, borneol, isobathol, methyl salicylate, and α-pinene to the internal standard peak area. The RSDs were 0.05%, 0.09%, 0.08%, 0.10%, 0.06%, and 0.09%, respectively, indicating good instrument precision. The results are shown in Table 5.

[0116] Table 5 Precision test results

[0117]

[0118]

[0119] Table 5 clearly shows that the precision of each active ingredient reaches over 99.9%, effectively ensuring the control of product quality.

[0120] 1.6.3 Stability Assessment

[0121] Take this product and prepare a sample solution according to the content determination method. Accurately pipette 1 μl of the same test solution and determine the content at 0, 2, 4, 6, 8, 10, and 12 hours according to the method. The RSDs of the ratios of the peak areas of camphor, menthol, borneol, isoborneol, methyl salicylate, and α-pinene to the peak area of ​​the internal standard were 0.07%, 0.10%, 0.12%, 0.09%, 0.06%, and 0.09%, respectively. The test solution was basically stable within 12 hours. The results are shown in Table 6.

[0122] Table 6. Stability Test Results

[0123]

[0124] As can be seen from Table 6, the stability of each active ingredient is excellent, with a stability of over 99.8%.

[0125] 1.6.4 Repeatability Test

[0126] Take this product and prepare 6 sample solutions according to the content determination method. Inject each solution separately, determine the peak area, and calculate the average content of camphor, menthol, borneol, isoborneol, methyl salicylate, and α-pinene using the internal standard method. The result is 21.02 mg / 100 cm⁻¹. 2 7.40mg / 100cm 2 15.39mg / 100cm 2 8.88mg / 100cm 2 22.47mg / 100cm 2 8.18mg / 100cm 2The RSDs were 0.65%, 0.85%, 0.52%, 0.53%, 1.36%, and 0.53%, respectively, as shown in Table 7. The results indicate that the method has good reproducibility.

[0127] Table 7 Results of Repeatability Tests

[0128]

[0129]

[0130] As can be seen from Table 7, the repeatability of the measurement method of the present invention is very good, with a repeatability efficiency of over 98%, and it has strong practical application value.

[0131] 1.6.5 Spiking and Recovery Experiment

[0132] Take this product (bronchitis rubber plaster with known content, batch number 210201), camphor 21.02mg / 100cm³. 2 Menthol content: 7.40 mg / 100 cm³ 2 Borneol content: 15.39 mg / 100 cm³ 2 Isorhoborneol 8.88mg / 100cm 2 Methyl salicylate 22.47 mg / 100 cm 2 α-pinene 8.10 mg / 100 cm 2 105cm 2 Take 6 portions; separately take 284.39 mg of camphor reference standard, 97.01 mg of menthol reference standard, 340.35 mg of borneol reference standard, 336.23 mg of isoborneol reference standard, 303.50 mg of methyl salicylate reference standard, and 75.66 mg of α-pinene reference standard, accurately weigh them, place them in the same 25 ml volumetric flask, dilute to the mark with ethyl acetate, and shake well to obtain a mixed reference solution (camphor 11.0343 mg / ml, menthol 3.7601 mg / ml, borneol 8.005 mg / ml, isoborneol 4.6400 mg / ml, methyl salicylate 12.1400 mg / ml, α-pinene 3.0235 mg / 100 cm³). 2 2 ml of each solution was precisely added and prepared according to the method under the content determination section. The reference solution and sample solution were precisely pipetted and injected into the gas chromatograph respectively. The contents of camphor, menthol, borneol, isoborneol and methyl salicylate were determined according to the method under the content determination section. The recovery rate was calculated. The results are shown in Tables 8-13.

[0133] Table 8. Results of Camphor Recovery Rate Test

[0134]

[0135] Table 9 Results of the menthol recovery rate test

[0136]

[0137]

[0138] Table 10 Results of the Borneol Recovery Rate Experiment

[0139]

[0140] Table 11 Results of the isorhamnet recovery rate test

[0141]

[0142] Table 12 Results of Methyl Salicylate Recovery Rate Test

[0143]

[0144] Table 13 Results of α-pinene recovery test

[0145]

[0146]

[0147] Experiment 2: Application of the measurement method of this invention in product quality control.

[0148] Twelve batches of bronchitis plaster samples were selected from the following companies: Henan Lingrui Pharmaceutical Co., Ltd. (batch numbers: 210201, 210202, 210203, 210301, 210302, 210501); Hunan Xinglinchun Pharmaceutical Co., Ltd. (batch numbers: 201205, 210101, 210301); and Jinzhou Zijin Pharmaceutical Co., Ltd. (batch numbers: 2012002, 2101205, 2103001). The results are shown in Table 14.

[0149] Table 14 Results of content determination in bronchitis plaster

[0150]

[0151] The table above shows that the average content of camphor, menthol, borneol, isoborneol, and methyl salicylate in bronchitis plaster is as follows per 100 cm³. 2 Contains camphor 21.08mg, menthol 7.57mg, borneol 15.48mg, isoborneol 8.48mg, methyl salicylate 21.73mg, and α-pinene 6.61mg; the theoretical value of the prescription is per 100cm³ 2It contains 24.05 mg of camphor, 8.05 mg of menthol, 27.85 mg of borneol (combined with isoborneol), 25.00 mg of methyl salicylate, and 6.55 mg of α-pinene. Based on the average content of the above 12 batches of samples, fluctuations in process parameters during production, and changes in content during storage, the content limit of this product is tentatively set as: per 100 cm³ of this product. 2 Contains camphor (C 10 H 16O Not less than 14.55 mg; Menthol (C 10 H 20O Not less than 5.00mg; contains borneol (C 10 H 18O Not less than 10.50 mg; contains isoborneol (C 10 H 18O The content of methyl salicylate (C8H8O3) shall not be less than 5.90 mg; the content of methyl salicylate (C8H8O3) shall not be less than 15.20 mg; and the content of α-pinene shall not be less than 4.55 mg. This can effectively control the quality of the product and ensure its efficacy.

[0152] As can be seen from the above, this invention provides for the first time a method for determining the quality of volatile drugs in bronchitis plaster. This method has high precision and accuracy in determining the quality of volatile drugs in bronchitis plaster, with an accuracy rate of over 99.9%, a stability rate of over 99.8%, and a repeatability rate of over 98%. The product quality is stable, uniform, and controllable. It can be effectively used to control the quality of bronchitis plaster products, ensuring the quality and efficacy of the plaster. This is a major innovation in the quality control of plaster products and has significant economic and social benefits.

Claims

1. A method for determining the quality of volatile drugs in a bronchitis adhesive plaster, characterized in that, The volatile medicinal components of the bronchitis plaster are camphor, borneol, menthol, methyl salicylate, and turpentine oil. Borneol contains borneol and isoborneol, and turpentine oil contains α-pinene. The content determination method is as follows: (1) Chromatographic conditions and system suitability test: A capillary column with a polyethylene glycol 20000 (PEG-20M) stationary phase, a length of 30 m, an inner diameter of 0.32 mm, and a film thickness of 0.50 μm was used. A programmed temperature ramp was employed: initial temperature 50–70 °C, held for 0–3 min, then increased to 180–220 °C at a rate of 3–9 °C / min, and held for 0–10 min. Split injection was used with a split ratio of 1–20:

1. The injection port temperature was 160–200 °C. An FID detector was used with a detector temperature of 220–250 °C. The carrier gas was 9.999% nitrogen, with a flow rate of 0.7–1.5 mL / min. (2) Preparation of internal standard solution: Take naphthalene, accurately weigh it, add ethyl acetate to prepare a solution containing 3 to 7 mg per 1 mL, and use it as internal standard solution; (3) Preparation of reference solution: Weigh 15-30 mg of camphor reference, 5-15 mg of menthol reference, 10-20 mg of borneol reference, 5-15 mg of isoborneol, 20-30 mg of methyl salicylate reference and 5-15 mg of α-pinene reference accurately, place them in the same 25 mL volumetric flask, add 5 mL of internal standard solution, dilute with ethyl acetate to 25 mL, shake well to prepare reference solution; (4) Preparation of sample solution: Take 210cm of bronchitis rubber plaster 2 Cut the sample into small pieces, remove the cap, place it in a 250mL flask, add 100mL of water, and follow the method of volatile oil determination in Section 2204, General Chapter, Chinese Pharmacopoeia 2020, until the water fills the graduated section and overflows into the flask. Add 2mL of toluene, heat under reflux for 1-4 hours, cool to room temperature, take the toluene solution, dilute with 3-5mL of ethyl acetate, filter through filter paper lined with anhydrous sodium sulfate, place the filtrate in a 50mL volumetric flask, wash the container and filter with 1-5mL of ethyl acetate 1-3 times, combine the washings in the same volumetric flask, accurately add 10mL of internal standard solution, dilute with ethyl acetate to 50mL, shake well to obtain the sample solution. (5) Determination method: Accurately pipette 1 μl of the reference solution and the sample solution into the gas chromatograph and measure them. Calculate the peak area of ​​the internal standard and the peak area of ​​the reference standard to obtain the correction factor. Calculate the content of volatile drugs in the sample solution using the correction factor. Equation (1) , Equation (2) , Equation (3) , In the formula: As This refers to the peak area or peak height of the internal standard. A R The peak area or peak height of the reference standard; Cs The concentration of the internal standard is mg / ml; C R The concentration of the reference standard is mg / ml; C X The concentration of the test sample is in mg / ml; A X The peak area or peak height of the test sample; A's The peak area or peak height of the internal standard in the test sample; C's The concentration of the internal standard in the test sample is expressed in mg / ml. M X The area of ​​the test sample is in cm². 2 .

2. The method for determining the quality of volatile drugs in bronchitis plaster according to claim 1, characterized in that, Includes the following steps: (1) Chromatographic conditions and system suitability test: A capillary column with a polyethylene glycol 20000 (PEG-20M) stationary phase, a length of 30 m, an inner diameter of 0.32 mm, and a film thickness of 0.50 μm was used. A programmed temperature ramp was employed: an initial temperature of 60 °C, held for 2 min, then increased to 200 °C at a rate of 7.5 °C / min, and held for 7 min. Split injection was used at a split ratio of 20:1; the injection port temperature was 180 °C; an FID detector was used at a detector temperature of 230 °C; and the carrier gas was 9.999% nitrogen at a flow rate of 0.8 mL / min. (2) Preparation of internal standard solution: Take naphthalene, accurately weigh it, add ethyl acetate to prepare a solution containing 5 mg per 1 mL, and use it as internal standard solution; (3) Preparation of reference solution: Take 25 mg of camphor reference, 10 mg of menthol reference, 15 mg of borneol reference, 10 mg of isoborneol, 25 mg of methyl salicylate reference and 10 mg of α-pinene reference, accurately weigh them, put them in the same 25 mL volumetric flask, add 5 mL of internal standard solution, dilute with ethyl acetate to 25 mL, shake well to make reference solution; (4) Preparation of sample solution: Take 210cm of bronchitis rubber plaster 2 Cut the sample into small pieces, remove the cap, place it in a 250mL flask, add 100mL of water, and follow the method of volatile oil determination in Section 2204 of the 2020 edition of the Chinese Pharmacopoeia, Volume IV, until the water fills the graduated section and overflows into the flask. Add 2mL of toluene, heat under reflux for 3 hours, cool to room temperature, take the toluene solution, dilute with 3mL of ethyl acetate, filter through filter paper lined with anhydrous sodium sulfate, place the filtrate in a 50mL volumetric flask, wash the container and filter with 1-5mL of ethyl acetate in 1-3 portions, combine the washings in the same volumetric flask, accurately add 10mL of internal standard solution, dilute with ethyl acetate to 50mL, shake well to obtain the sample solution. (5) Determination method: Accurately pipette 1 μl of the reference solution and the sample solution into the gas chromatograph and measure them. Calculate the peak area of ​​the internal standard and the peak area of ​​the reference standard to obtain the correction factor. Calculate the content of volatile drugs in the sample solution through the correction factor.

3. The method for determining the quality of volatile drugs in bronchitis adhesive plaster according to claim 1, characterized in that, Includes the following steps: (1) Chromatographic conditions and system suitability test: A capillary column with a polyethylene glycol 20000 (PEG-20M) stationary phase, a length of 30 m, an inner diameter of 0.32 mm, and a film thickness of 0.50 μm was used. A programmed temperature ramp was employed: an initial temperature of 60 °C, held for 2 min, then increased to 200 °C at a rate of 7.5 °C / min, and held for 5 min. The sample was injected into the capillary column by split injection at a split ratio of 15:

1. The injection port temperature was 170 °C. An FID detector was used at a temperature of 240 °C. The carrier gas was 9.999% nitrogen at a flow rate of 1.0 mL / min. (2) Preparation of internal standard solution: Take naphthalene, accurately weigh it, add ethyl acetate to prepare a solution containing 4 mg per 1 mL, and use it as internal standard solution; (3) Preparation of reference solution: Weigh 16 mg of camphor reference, 6 mg of menthol reference, 12 mg of borneol reference, 6 mg of isoborneol, 22 mg of methyl salicylate reference and 6 mg of α-pinene reference accurately, place them in the same 25 mL volumetric flask, add 5 mL of internal standard solution, dilute with ethyl acetate to 25 mL, shake well to prepare reference solution; (4) Preparation of sample solution: Take 210cm of bronchitis rubber plaster 2 Cut the sample into small pieces, remove the cap, place it in a 250mL flask, add 100mL of water, and follow the method of volatile oil determination in Section 2204 of the 2020 edition of the Chinese Pharmacopoeia, Volume IV, until the water fills the graduated section and overflows into the flask. Add 2mL of toluene, heat under reflux for 2 hours, cool to room temperature, take the toluene solution, dilute with 4mL of ethyl acetate, filter through filter paper lined with anhydrous sodium sulfate, place the filtrate in a 50mL volumetric flask, wash the container and filter with 1-5mL of ethyl acetate in 1-3 portions, combine the washings in the same volumetric flask, accurately add 10mL of internal standard solution, dilute with ethyl acetate to 50mL, shake well to obtain the sample solution. (5) Determination method: Accurately pipette 1 μl of the reference solution and the sample solution into the gas chromatograph and measure them. Calculate the peak area of ​​the internal standard and the peak area of ​​the reference standard to obtain the correction factor. Calculate the content of volatile drugs in the sample solution through the correction factor.

4. The method for determining the quality of volatile drugs in bronchitis adhesive plaster according to claim 1, characterized in that, Includes the following steps: (1) Chromatographic conditions and system suitability test: A capillary column with a polyethylene glycol 20000 (PEG-20M) stationary phase, a length of 30 m, an inner diameter of 0.32 mm, and a film thickness of 0.50 μm was used. A programmed temperature ramp was employed: an initial temperature of 60 °C, held for 2 min, then increased to 200 °C at a rate of 6 °C / min, and held for 6 min. Split injection was used with a split ratio of 10:1; the injection port temperature was 190 °C; an FID detector was used with a detector temperature of 230 °C; and the carrier gas was 9.999% nitrogen at a flow rate of 1.4 mL / min. (2) Preparation of internal standard solution: Take naphthalene, accurately weigh it, add ethyl acetate to prepare a solution containing 6 mg per 1 mL, and use it as internal standard solution; (3) Preparation of reference solution: Take 28 mg of camphor reference, 13 mg of menthol reference, 18 mg of borneol reference, 13 mg of isoborneol, 28 mg of methyl salicylate reference and 13 mg of α-pinene reference, accurately weigh them, put them in the same 25 mL volumetric flask, add 5 mL of internal standard solution, dilute with ethyl acetate to 25 mL, shake well to make reference solution; (4) Preparation of sample solution: Take 210cm of bronchitis rubber plaster 2 Cut the sample into small pieces, remove the cap, place it in a 250mL flask, add 100mL of water, and follow the method of volatile oil determination in Section 2204 of the 2020 edition of the Chinese Pharmacopoeia, Volume IV, until the water fills the graduated section and overflows into the flask. Add 2mL of toluene, heat under reflux for 4 hours, cool to room temperature, take the toluene solution, dilute with 5mL of ethyl acetate, filter through filter paper lined with anhydrous sodium sulfate, place the filtrate in a 50mL volumetric flask, wash the container and filter with 1-5mL of ethyl acetate 1-3 times, combine the washings in the same volumetric flask, accurately add 10mL of internal standard solution, dilute with ethyl acetate to 50mL, shake well to obtain the sample solution. (5) Determination method: Accurately pipette 1 μl of the reference solution and the sample solution into the gas chromatograph and measure them. Calculate the peak area of ​​the internal standard and the peak area of ​​the reference standard to obtain the correction factor. Calculate the content of volatile drugs in the sample solution through the correction factor.

5. The method for determining the quality of volatile drugs in bronchitis adhesive plaster according to any one of claims 1-4 is used in the quality control of volatile drugs in bronchitis adhesive plaster.

Citation Information

Patent Citations

  • Paste for treating and preventing trachitis and preparation method thereof

    CN104208322A

  • Method for measuring content of volatile components in high-activity transdermal emplastrum

    CN113588852A